REAL-WORLD ANALYSIS OF PATIENTS WITH CLL TREATED WITH IBRUTINIB: A RETROSPECTIVE ANALYSIS OF THE BRAZILIAN REGISTRY OF CLL

REAL-WORLD ANALYSIS OF PATIENTS WITH CLL TREATED WITH IBRUTINIB: A RETROSPECTIVE ANALYSIS OF THE BRAZILIAN REGISTRY OF CLL

Introduction: Ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, is associated with increased survival and prolonged response, even in high-risk scenarios, with relatively low toxicity compared to chemoimmunotherapy. However, a significant number of patients discontinue therapy due to intol...

Full description

Saved in:
Bibliographic Details
Main Authors: V Pfister, FM Marques, R Santucci, V Buccheri, G Ribeiro, VLP Figueiredo, N Hamerschlak, A Costa, T Silveira, A Scheliga, L Perobelli, CS Chiattone, C Arrais-Rodrigues
Format: Article
Language:English
Published: Elsevier 2024-10-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137924008824
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items